John B. Green, Chief Financial Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 51,248 shares at $22.95 ($1.2M) on 2020-04-20, disclosed to the SEC on 2020-04-22.
Open-market sale of $1.2M DRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.95 | 25,624 | $588K | 50.0% |
| 2 | $22.95 | 25,624 | $588K | 50.0% |
| Total | $22.95 avg | 51,248 | $1.2M | 100% |
| Filing → |
| DRNA | SELL | 2019-11-27 | $312K | — | Filing → |
| DRNA | SELL | 2019-11-20 | $263K | — | Filing → |
| DRNA | SELL | 2019-11-15 | $71K | — | Filing → |